Ovarian cancer

Opportunity for targeted therapy

Tomoko Tagawa, Robert Morgan, Yun Yen, Joanne Mortimer

Research output: Contribution to journalReview article

27 Citations (Scopus)

Abstract

Ovarian cancer is a common cause of cancer mortality in women with limited treatment effectiveness in advanced stages. The limitation to treatment is largely the result of high rates of cancer recurrence despite chemotherapy and eventual resistance to existing chemotherapeutic agents. The objective of this paper is to review current concepts of ovarian carcinogenesis. We will review existing hypotheses of tumor origin from ovarian epithelial cells, Fallopian tube, and endometrium. We will also review the molecular pathogenesis of ovarian cancer which results in two specific pathways of carcinogenesis: (1) type I low-grade tumor and (2) type II high-grade tumor. Improved understanding of the molecular basis of ovarian carcinogenesis has opened new opportunities for targeted therapy. This paper will also review these potential therapeutic targets and will explore new agents that are currently being investigated.

Original languageEnglish
Article number682480
JournalJournal of Oncology
DOIs
Publication statusPublished - Jan 13 2012
Externally publishedYes

Fingerprint

Ovarian Neoplasms
Carcinogenesis
Neoplasms
Therapeutics
Fallopian Tubes
Endometrium
Epithelial Cells
Recurrence
Drug Therapy
Mortality

ASJC Scopus subject areas

  • Oncology

Cite this

Ovarian cancer : Opportunity for targeted therapy. / Tagawa, Tomoko; Morgan, Robert; Yen, Yun; Mortimer, Joanne.

In: Journal of Oncology, 13.01.2012.

Research output: Contribution to journalReview article

Tagawa, Tomoko ; Morgan, Robert ; Yen, Yun ; Mortimer, Joanne. / Ovarian cancer : Opportunity for targeted therapy. In: Journal of Oncology. 2012.
@article{0ee543cc38814589a22e0fd045a88da1,
title = "Ovarian cancer: Opportunity for targeted therapy",
abstract = "Ovarian cancer is a common cause of cancer mortality in women with limited treatment effectiveness in advanced stages. The limitation to treatment is largely the result of high rates of cancer recurrence despite chemotherapy and eventual resistance to existing chemotherapeutic agents. The objective of this paper is to review current concepts of ovarian carcinogenesis. We will review existing hypotheses of tumor origin from ovarian epithelial cells, Fallopian tube, and endometrium. We will also review the molecular pathogenesis of ovarian cancer which results in two specific pathways of carcinogenesis: (1) type I low-grade tumor and (2) type II high-grade tumor. Improved understanding of the molecular basis of ovarian carcinogenesis has opened new opportunities for targeted therapy. This paper will also review these potential therapeutic targets and will explore new agents that are currently being investigated.",
author = "Tomoko Tagawa and Robert Morgan and Yun Yen and Joanne Mortimer",
year = "2012",
month = "1",
day = "13",
doi = "10.1155/2012/682480",
language = "English",
journal = "Journal of Oncology",
issn = "1687-8450",
publisher = "Hindawi Publishing Corporation",

}

TY - JOUR

T1 - Ovarian cancer

T2 - Opportunity for targeted therapy

AU - Tagawa, Tomoko

AU - Morgan, Robert

AU - Yen, Yun

AU - Mortimer, Joanne

PY - 2012/1/13

Y1 - 2012/1/13

N2 - Ovarian cancer is a common cause of cancer mortality in women with limited treatment effectiveness in advanced stages. The limitation to treatment is largely the result of high rates of cancer recurrence despite chemotherapy and eventual resistance to existing chemotherapeutic agents. The objective of this paper is to review current concepts of ovarian carcinogenesis. We will review existing hypotheses of tumor origin from ovarian epithelial cells, Fallopian tube, and endometrium. We will also review the molecular pathogenesis of ovarian cancer which results in two specific pathways of carcinogenesis: (1) type I low-grade tumor and (2) type II high-grade tumor. Improved understanding of the molecular basis of ovarian carcinogenesis has opened new opportunities for targeted therapy. This paper will also review these potential therapeutic targets and will explore new agents that are currently being investigated.

AB - Ovarian cancer is a common cause of cancer mortality in women with limited treatment effectiveness in advanced stages. The limitation to treatment is largely the result of high rates of cancer recurrence despite chemotherapy and eventual resistance to existing chemotherapeutic agents. The objective of this paper is to review current concepts of ovarian carcinogenesis. We will review existing hypotheses of tumor origin from ovarian epithelial cells, Fallopian tube, and endometrium. We will also review the molecular pathogenesis of ovarian cancer which results in two specific pathways of carcinogenesis: (1) type I low-grade tumor and (2) type II high-grade tumor. Improved understanding of the molecular basis of ovarian carcinogenesis has opened new opportunities for targeted therapy. This paper will also review these potential therapeutic targets and will explore new agents that are currently being investigated.

UR - http://www.scopus.com/inward/record.url?scp=84855604744&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84855604744&partnerID=8YFLogxK

U2 - 10.1155/2012/682480

DO - 10.1155/2012/682480

M3 - Review article

JO - Journal of Oncology

JF - Journal of Oncology

SN - 1687-8450

M1 - 682480

ER -